ABCELLERA BIOLOGICS INC shareholders Q3 2023

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.

ABCELLERA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$17,358,23889.37%
Founders Fund Growth Management, LLC 407,017$1,872,2785.10%
Prosight Management, LP 2,446,000$11,251,6003.57%
Intellectus Partners, LLC 876,633$4,032,5111.28%
Belmont Capital, LLC 510,000$2,346,0001.27%
Casdin Capital, LLC 2,360,129$10,856,5931.20%
GUARDIAN CAPITAL ADVISORS LP 1,786,414$7,842,3570.88%
Baker Brothers Advisors 20,763,323$95,511,2860.55%
BRANDYWINE MANAGERS, LLC 56,976$262,0900.44%
Orbimed Advisors 4,180,768$19,231,5330.41%
Novo Holdings A/S 1,126,915$5,183,8090.38%
ArrowMark Colorado Holdings LLC 4,105,095$18,883,4370.23%
EPIQ Capital Group, LLC 86,291$396,9390.21%
ArchPoint Investors 115,055$529,2530.20%
Green Alpha Advisors, LLC 39,364$181,0740.14%
PDT Partners, LLC 210,076$966,3500.12%
Bridgefront Capital, LLC 35,905$165,1630.12%
Baillie Gifford 26,204,649$120,541,3850.11%
Duquesne Family Office 659,750$3,0350.11%
DARK FOREST CAPITAL MANAGEMENT LP 278,618$1,281,6430.10%
External links

This page lists ABCELLERA BIOLOGICS INC's shareholders in Q3 2023. To view ABCELLERA BIOLOGICS INC's shareholder history, click here.